Every one of those 1 sits in a single category, health-it. Of the tracked stories, 1 of 1 also mention 908 Devices, the most common co-covered peer. We currently track 1 Healthcare story that mention EVgo, all published on March 3, 2026.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about EVgo
Every one of those 1 sits in a single category, health-it. Of the tracked stories, 1 of 1 also mention 908 Devices, the most common co-covered peer. We currently track 1 Healthcare story that mention EVgo, all published on March 3, 2026. Each carries 3 original sources on average.
Stories tracked
1
Sources per story
3
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 4 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering EVgo. Shared-story counts are live from our verified record — not editorial picks.
908 Devices (MASS) reported a strong Q4, beating both top and bottom-line estimates and introducing a positive FY26 outlook. The results signal a recovery in the life sciences tools sector, driven by the adoption of point-of-need mass spectrometry in bioprocessing and forensics.